T. Rowe Price Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 14,168,116 shares of IONS stock, worth $518 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
14,168,116
Previous 12,639,684
12.09%
Holding current value
$518 Million
Previous $602 Million
5.78%
% of portfolio
0.34%
Previous 0.38%
Shares
9 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$550 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$377 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$319 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$288 Million5.32% of portfolio
-
Capital World Investors Los Angeles, CA7.83MShares$286 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.19B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...